Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark.
| Revenue (Most Recent Fiscal Year) | $783.76M |
| Net Income (Most Recent Fiscal Year) | $34.17M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | 82.89 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 4.41 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.43 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 27.34 |
| Pre-Tax Margin (Trailing 12 Months) | 5.56% |
| Net Margin (Trailing 12 Months) | 6.21% |
| Return on Equity (Trailing 12 Months) | 6.31% |
| Return on Assets (Trailing 12 Months) | 4.97% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.88 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.47 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.08 |
| Inventory Turnover (Trailing 12 Months) | 2.20 |
| Book Value per Share (Most Recent Fiscal Quarter) | $3.55 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $0.19 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 234.97M |
| Free Float | -- |
| Market Capitalization | $3.70B |
| Average Volume (Last 20 Days) | 561.25 |
| Beta (Past 60 Months) | 1.45 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.03 |
| Dividend Yield (Based on Last Quarter) | 0.18% |